Pasithea Therapeutics Corp.
$0.00
+0.00 (+0.00%)
Price as of Sep 16, 2026 market close
Performance
- 1 Month
- -59.4%
- 3 Months
- -57.6%
- YTD
- -80.1%
- 1 Year
- -79.6%
- 3 Year annualized
- -40.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 469.9%
- Largest decline max drawdown, since Sep 2021
- -99.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.31
Own KTTAW?
See how KTTAW contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.